'House of the Dragon' star Milly Alcock cast as Kara Zor-El in DC Studios' 'Supergirl' film
"House of the Dragon" breakout star Milly Alcock is the newest addition to the DC Universe.
The Australian actor has been cast as Supergirl — aka Superman's cousin, Kara Zor-El — in the upcoming film "Supergirl: Woman of Tomorrow," DC Studios CEO James Gunn confirmed in an Instagram post Monday.
Gunn shared a screenshot of Deadline's article announcing the news in his post, writing, "This is accurate. Milly is a fantastically talented young actor, and I’m incredibly excited about her being a part of the DCU."
He added: "Yes, I first became aware of her in House of the Dragon but I was blown away by her varied auditions and screen tests for #Supergirl." The "Guardians of the Galaxy" director said Alcock "embodies Kara" as envisioned by "Supergirl: Woman of Tomorrow" author Tom King and illustrator Bilquis Evely.
Shortly after Gunn's social media announcement, Alcock shared his post to her Instagram Story, writing, "Ahhh thank you" in all-caps.
USA TODAY has reached out to a representative for Warner Bros. for comment.
Alcock, who made her television debut in 2014, appeared in several series before the 23-year-old landed her biggest role to date as Princess Rhaenyra Targaryen in the "Game of Thrones" prequel "House of the Dragon." Co-star Emma D'Arcy played an older version of Rhaenyra later in Season 1.
Other actors who have taken on the role of Supergirl include Melissa Benoist ("Supergirl" on CBS and CW) and Sasha Calle (2023's “The Flash").
Gunn's "Superman: Legacy" — starring Isabela Merced (Hawkgirl), Nicholas Hoult (Lex Luthor), Nathan Fillion (Guy Gardner), Rachel Brosnahan (Lois Lane) and David Corenswet (the DC Universe's new Superman) — is currently in the works, slated for a July 11, 2025, release.
Meet your new Supergirl:Sasha Calle takes flight as an 'incredible' hero in 'The Flash'
'House of the Dragon':Sex, death, fire and blood are back in season premiere
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.